NSE › Healthcare

Mankind Pharma Ltd (MANKIND)

NSE · Healthcare · Drug Manufacturers - Specialty & Generic

₹2,483.00+0.54%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
₹3,443 cr
Revenue YoY
+14.5%
Net profit
₹554 cr
Profit YoY
+31.7%
EPS
₹13.89
EPS estimate
₹9.90
Net margin
16.1%

EPS came in at 13.89 against a street estimate of 9.90 — a beat of 40.3%.

Key statistics

Market cap
₹1.01 lakh cr
P/E
49.6
Forward P/E
39.5
P/B
6.26
Book value
₹394.85
EPS (TTM)
₹49.39
52-week high
₹2,674.00
52-week low
₹1,909.70
50-day MA
₹2,467.56
200-day MA
₹2,266.50
Beta
0.45

Analyst view

with an average price target of ₹2,736.47.

Shareholding

Promoters
75.40%
Institutions
20.15%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Mankind Pharma Ltd — free to start.

Google PlayApp Store

Other Healthcare companies

Sun Pharmaceutical Industries LimitedDivi's Laboratories LimitedTorrent Pharmaceuticals LimitedApollo Hospitals Enterprise LimitedCipla LimitedZydus Lifesciences LimitedLupin LimitedMax Healthcare Institute LimitedLaurus Labs LimitedLenskart Solutions LtdDr. Reddy's Laboratories LimitedAurobindo Pharma Limited

Data updated 2026-08-05.